GLUT-2 mediated glucose uptake analysis of Duranta repens: In-silico and In-vitro approach
- 14 February 2022
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (1) , 419-427
Abstract
Background Type-2 diabetes mellitus is a common metabolic disorder characterized by insulin resistance, a relative impairment in insulin secretion, and a certain degree of genetic predisposition. The rapid rise in the prevalence of diabetes mellitus around the world has assisted in the development of new pharmacologically active compounds. The current study was aimed to investigate and validate the anti-diabetic activity of wild-grown plant Duranta repens L. Material and methods In-silico molecular docking via AutoDock tools 4.2 and in-vitro glucose uptake assay using yeast cells was performed to investigate the anti-diabetic property of plant Duranta repens. Further, mRNA-based gene ontology enrichment analysis was performed to predict the imitated ontology by the bio-actives from Duranta repens. Results The in-silico study results reveal that among the 9 active phytoconstituents docked against GLUT-2 protein, α-onocerin possessed the highest binding affinity of -10.23 kcal/mol with no predicted adverse effects and also complies with Lipinski’s rule of five. Also, in-vitro studies reflected in a 5 mM glucose solution, hydro-alcoholic extract of Duranta repens at different concentrations enhanced glucose uptake in yeast cells. Conclusion Duranta repens extract enhanced the glucose uptake in yeast cells which may be due to the presence of α-onocerin; possessed the better interaction. Also, no adverse effects were predicted for α-onocerin. Thus, it can be speculated that Duranta repens may possess anti-diabetic activity which may be due to α-onocerin and other related bioactives; needs to be further confirmed via experimental studies.Keywords
This publication has 32 references indexed in Scilit:
- PubChem Substance and Compound databasesNucleic Acids Research, 2015
- DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formulaBioinformatics, 2013
- Mechanisms of glucose uptake in intestinal cell lines: Role of GLUT2Surgery, 2012
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Medicinal plant species with potential antidiabetic propertiesJournal of the Science of Food and Agriculture, 2007
- UniProtKB/Swiss-Prot2007
- SWISS-MODEL: an automated protein homology-modeling serverNucleic Acids Research, 2003
- Characterisation of glucose transport inSaccharomyces cerevisiaewith plasma membrane vesicles (countertransport) and intact cells (initial uptake) with single Hxt1, Hxt2, Hxt3, Hxt4, Hxt6, Hxt7 or Gal2 transportersFEMS Yeast Research, 2002
- Different Functional Domains of GLUT2 Glucose Transporter Are Required for Glucose Affinity and Substrate Specificity1Endocrinology, 1998
- Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic isletsDiabetologia, 1989